Coeliac disease in infants: antibodies to deamidated gliadin peptide come first!

Michele Arigliani1, Francesca Rech Morassutti2, Martina Fabris3

  • 1Department of Clinical and Experimental Medical Sciences, Unit of Pediatrics, University Hospital of Udine, Piazzale S. Maria Misericordia 1, 33100, Udine, Italy. michelearigliani@gmail.com.

Insights

Antibodies to deamidated gliadin peptides (anti-DGPs) are useful for diagnosing coeliac disease (CD) in infants. This case report shows anti-DGPs can aid early CD diagnosis when other tests are negative.

Area of Science:

  • Pediatric Gastroenterology
  • Immunology
  • Genetics

Background:

  • Coeliac disease (CD) diagnosis in infants is challenging due to low antibody sensitivity and overlapping symptoms with other malabsorption disorders.
  • Antibodies to deamidated gliadin peptides (anti-DGPs), particularly IgG, may be detected earlier than IgA anti-tissue transglutaminase (tTG) in young children with CD.

Purpose of the Study:

  • To highlight the diagnostic utility of anti-DGPs in an infant with suspected coeliac disease.
  • To present a rare case of biopsy-proven CD in an infant with a unique antibody profile.

Main Methods:

  • Case report of an 8-month-old infant presenting with failure to thrive, constipation, and developmental delay post-gluten introduction.
  • Laboratory evaluation included fecal elastase, IgA, anti-DGPs (IgG and IgA), and anti-tTG antibodies.
  • Duodenal biopsy, genetic testing (HLA-DQ2/DQ8), and response to a gluten-free diet were assessed.

Main Results:

  • The infant showed high fecal elastase, normal IgA, positive IgG and IgA anti-DGPs, and negative anti-tTG.
  • Duodenal biopsy confirmed complete villous atrophy (Marsh-Oberhuber 3C).
  • Genetic testing revealed HLA-DQ2 and HLA-DQ8 positivity. Symptoms resolved, and development normalized on a gluten-free diet.

Conclusions:

  • Anti-DGPs are valuable for screening infants with suspected CD, especially when anti-tTG is negative.
  • The isolated positivity of IgG and IgA anti-DGPs in an IgA-competent child with biopsy-proven CD is rare and may be attributed to immune system immaturity in infancy.
Abstract

Related Concept Videos

Development of Immunocompetence01:22

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
1.0K
Gastritis-II: Pathophysiology01:17

Gastritis-II: Pathophysiology

Gastritis is marked by disruption of the mucosal barrier that usually protects the stomach tissue from digestive juices and manifests in acute and chronic forms.
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
1.5K
Transcytosis of IgG01:15

Transcytosis of IgG

Transcytosis is the process in which molecules are internalized by endocytosis, transported across the cell, and released through exocytosis from the opposite end of the cell. Molecules such as insulin, immunoglobulins, and certain nutrients are transferred through the recycling endosomes by recycling and transcytosis.
IgG molecules from a mother undergo transcytosis starting around 13 weeks of gestation. The amount of IgG transferred and entering the fetal blood circulation increases with...
4.3K